The daily administration of high CBD, low THC extracts is safe and effective in treating symptoms related to pediatric movement disorders, according to clinical trial data published in the Journal of Child Neurology. Israeli researchers assessed the adjunctive use of CBD extracts in 20 patients with moderate to severe complex motor disorders over a period of five months. […]

WEDNESDAY, May 16, 2018 (HealthDay News) — Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests. Patients taking a 10-milligram (mg) daily dose of pharmaceutical grade cannabidiol (CBD) experienced nearly as great a reduction in seizures as patients on 20 mg, and with […]

Tilray Canada has launched its newest product, Tilray 2:100, a formulation of therapeutic cannabis oil containing a high concentration of cannabidiol (CBD), which may help treat Canadian patients with conditions like Dravet syndrome. “We are excited to offer this highly concentrated CBD product to patients in Canada. We developed this product around a strong existing evidence […]

Marissa Morrison, KIVI Idaho   Published at 12:34 pm, April 29, 2018 BOISE – The Food and Drug Administration is one step closer to approving a prescription CBD oil. Participants in an Idaho case study may have played a role in the decision-making process. A panel of federal advisers unanimously voted last week to recommend the […]

The green rush has officially arrived. Once derided as the scourge of America’s youth, cannabis is now being touted as one of the country’s biggest potential cash crops. As of 2018, 18 states and the District of Columbia have legalized medical marijuana use and sales, with a further eight states allowing for recreational use. According […]

Recently, INSYS Therapeutics, Inc. INSY , a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, recently initiated a Phase 2 clinical trial of its cannabidiol (CBD) oral solution for evaluation of safety and efficacy in pediatric patients with Prader-Willi syndrome, a rare genetic disease characterized by insatiable appetite in children that […]

Epidiolex ist eine Cannabidiol-Lösung zum Einnehmen bei Patienten mit LGS, einer seltenen, schweren Form der Epilepsie, die im Kindesalter beginnt und schwierig zu behandeln ist. Aber auch beim Dravet-Syndrom soll das Arzneimittel zur Anwendung kommen. Der Hersteller GW hatte die Zulassung im Januar beantragt. „Wir befinden uns derzeit in der letzten Überprüfungsphase des Arzneimittelzulassungsantrags für […]

COLUMBUS (WCMH) – Children and adults with a severe and complex form of epilepsy called Lennox-Gastaut Syndrome can have hundreds of seizures each day.  A cannabis-derived treatment studied at Nationwide Children’s Hospital is showing impressive results in reducing those seizures, bringing hope to families. It’s a part of an international study, with 30 centers participating in […]